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INTRODUCTION:  Myotonic  dystrophies  are  inherited  multisystemic  diseases  characterized  by  musculopa-
thy, cardiac  arrythmias  and  cognitive  disorders.  These  patients  are  at increased  risk  for  fatal  post-surgical
complications  from  pulmonary  hypoventilation.  We  present  a case  with  myotonic  dystrophy  and
esophageal  cancer  who  had  a minimally  invasive  esophagectomy  complicated  with  gastrobronchial
ﬁstulisation.
PRESENTATION  OF  CASE:  A 44-year-old  male  with  myotonic  dystrophy  type  1 and  esophageal  cancer
had  a minimally  invasive  esophagectomy  performed  instead  of open  surgery  in order  to  reduce  the
risk for  pulmonary  complications.  At day  15  respiratory  failure  occurred  from  a gastrobronchial  ﬁstula
between  the  right intermediary  bronchus  (defect  7–8  mm)  and  the  esophagogastric  anastomosis  (defect
10 mm).  In  order  to  minimize  large  leakage  of air  into  the  gastric  conduit  the  anastomosis  was  stented  and
ventilation maintained  at low  airway  pressures.  His  general  condition  improved  and  allowed  extubation
at  day  29  and  stent  removal  at day  35. Bronchoscopy  conﬁrmed  that  the  ﬁstula  was  healed.  The patient
was  discharged  from  hospital  at day  37  without  further  complications.
DISCUSSION:  The  ﬁstula  was probably  caused  by  bronchial  necrosis  from  thermal  injury  during  close
dissection  using  the Ligasure  instrument.  Fistula  treatment  by non-surgical  intervention  was  considered
safer  than surgery  which  could  be  followed  by  potentially  life-threatening  respiratory  complications.
Indications  for stenting  of  gastrobronchial  ﬁstulas  will  be  discussed.
CONCLUSIONS:  Minimally  invasive  esophagectomy  was  performed  instead  of open  surgery  in  a myotonic
dystrophy  patient  as these  patients  are  particularly  vulnerable  to  respiratory  complications.  Gastro-
bronchial  ﬁstula,  a major  complication,  was  safely  treated  by  stenting  and  low  airway  pressure  ventilation.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. IntroductionMyotonic dystrophies (MD) are autosomal dominant inher-
ted multisystemic diseases characterized by symptoms including
arying degrees of musculopathy, cognitive disorders and cardiac
Abbreviations: MIE, minimally invasive esophagectomy; MD,  myotonic dystro-
hy.
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arrythmias [1]. It exists in two  forms of which MD  type 1 is the clas-
sic variant known as Steinertı´s disease with more severe symptoms
than MD type 2, also known as proximal myotonic myopathy. The
gene defect of DM type 1 was  discovered in 1992 and found to be a
mutation of the myotonic dystrophy protein kinase gene located on
chromosome 19q13.3.3 which codes for a myosin kinase expressed
in skeletal muscle. In patients with a clinical picture of MD  2 the
mutation is on chromosome 3. The estimated prevalence of MD 1
and MD 2 are about 1/8000 each, respectively.
The most crucial element afﬂicting surgery in MD patients is the
effect on respiration postoperatively because of myopathy of res-
piratory muscles that increase the risk for pneumonia, atelectasis
and ventilatory failure [2,3].
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. At day seven the esophagogastric anastomsis (arrow) was found intact asCASE  REPORT
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MD  is associated with increased risk of cancer. A Swedish and
anish study [4], including 1658 patients, generally disclosed a
wo-fold incidence ratio for cancer compared with the general pop-
lation, and most pronounced (5–7-fold) for malignancy of the
ndometrium, ovary, colon and brain [4]. There are no studies
eporting cancer of the esophagus.
We report for the ﬁrst time a MD  type 1 patient who  was  oper-
ted for esophageal cancer. The method used was a minimally
nvasive esophagectomy (MIE) in order to reduce the risk for res-
iratory failure. Gastrobronchial ﬁstula (GBF) occurred as a major
omplication and was successfully treated with esophagogastric
tenting and low pressure mechanical ventilation. Experience and
equirements for stenting of gastrobronchial ﬁstulas involving the
sophagogastric anastomosis will be discussed.
. Case presentation
A 44-year-old male of Norwegian ethnicity with a maternally
nherited MD  type 1, had a moderate functional disability in daily
ife, partially dependent on a wheel chair, but was able to walk
bout 500 m.
He presented with dysphagia and weight loss. Endoscopy
evealed Barrettı´s esophagus at 35–40 cm from the incisors,
ncluding a malignant stricture at 35 cm.  Biopsies showed adeno-
arcinoma. There was no evidence of metastasis based on computed
omography (CT). Echocardiography (ECG) showed atrioventricular
lock type I and left posterior fascicular block. Spirometry demon-
trated a moderate restriction (FVC 325l, 75% of predicted, FEV1
4% of predicted). Alveolar gas diffusion capacity and peripheral
enous oxygen saturation were normal. The patient was  consid-
red unsuitable for conventional open surgery owing to the risk of
yopathic postoperative respiratory failure.
He was operated in April 2012 with MIE  in the left lateral
osition [5]; Laparscopic gastric resection converting the gas-
ric remnant into a 4–5 cm wide tube. Thoraco-scopic esophageal
esection and construction of a mediastinal stapled functional end-
o-end esophagogastrostomy was done. Dissection using bipolar
igasure with blunt tip posterior to esophagus and close to the
ight main bronchus was part of the procedure. The esophagus
as transected with endo GIA (violet magazine) 10 mm caudal to
he azygos vein. Macroscopically there were 2 cm free resection
argin proximal to the tumor. Histology revealed a low differen-
iated adenocarcinoma staged T3N2Mx with tumor inﬁltration in
he circumferential resection margin.
The patient was extubated without complications the ﬁrst day
ostoperatively but reintubated the second day because of pneu-
onia and respiratory failure. A chest X-ray revealed atelectasis of
he right lower lobe and bronchoscopic clearance of excess mucus
n the bronchial tree was necessary. He was extubated on the third
ay and the patient had intermittent nocturnal non-invasive ven-
ilation because of hypoventilation episodes and sleep apnea. At
ay seven the esophagogastric anastomosis was intact as judged by
ral contrast X-ray enema (Fig. 1). Spirometry on day 11 showed
igniﬁcant reductions of FVC and FEV1 in the supine position and a
estrictive spirometry indicating poor diaphragmatic function.
Unexpectedly, on day 15 postoperatively respiratory failure
eveloped with oxygen desaturation, hypotension, tachypnea and
igns of septicemia. ECG was normal. Bronchoscopy demonstrated
 ﬁstula with diameter 7–8 mm localized medially in the right inter-
ediary bronchus distal to the upper lobe bronchus and proximal
o the middle lobe bronchus. Through the ﬁstula the mediastinal
tructures and the stapler sutures of the anastomosis were visible.
astroscopy revealed the gastroesophageal anastomosis located
0 cm from the incisor line. In the stapler row at the edge of the
nastomosis, there was an oval ﬁstula with maximum length ofjudged by oral contrast enema.
10 mm.  Intubation and mechanical ventilation was established.
Ventilator readings showed a considerable gas leakage caused by
gas escaping and emptying via the bronchial ﬁstula to the medi-
astinum and the gastroesophageal ﬁstula. To cover the perforation
to reduce air leakage an endoluminal 105 mm long partially covered
Wall ﬂex stent with core diameter 23 mm and end diameter 28 mm
(lot. 1444010, Boston Scientiﬁc, Natick, MA,  USA,) was placed in
the esophageal and gastric remnant. This stent was  covered with
a thin polyurethane layer except from the bare distal and proxi-
mal  1,5 cm that reduces the risk for migration. This wide diameter
stent was also considered beneﬁcial by reducing the peristalsis in
the gastric conduit and thus improve the tegmentation of the GBF.
The leakage of gas through the ﬁstula was minimalized by using
low peak airway pressures during mechanical ventilation, being
reduced from 20 to 8 mm Hg. Two  days later a thoracic CT scan
demonstrated bilateral pleural effusion, lung consolidation and a
small but visible ﬁstulous communication from the gastric tube to
the rigth intermediary bronchus (Fig. 2). On day 18 postoperatively
percutaneous tracheotomy was performed. His general condition
improved with resolution of the pleural effusion and pneumonia
(Fig. 3) and allowed extubation on day 29 postoperatively. The stent
was removed on day 35, and both gastroscopy and bronchoscopy
conﬁrmed that the ﬁstula was  healed.
The patient was discharged from hospital 2 days later and was
followed in the out-patient clinic. The postoperative course was
uncomplicated until recurrence after 9 months and ultimately
death from mediastinal and pulmonary metastases 11 months
postoperatively.
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onsolidation.
. Discussion
We  outline the treatment of a high risk patient who  had MD
ype 1 and esophageal cancer.
The reports on surgery in patients with DM are limited [2,3,6].
n the largest series of 219 cases [3], the patients had either lim-
ted peripheral surgery including procedures on eye, nose and
hroat and vagina, or abdominal operations like hysterectomy,
ubal ligation, appendectomy, cesarean section and cholecystec-
omy. Concerning thoracic surgery we found only one series of six
atients with MD  type 1 and Barlow disease [6] who had complex
itral valve surgery during hypothermic cardiopulonary bypass
nd cardioplegia. MIE  for esophageal cancer in a patient with DM
as not been previously reported. Our patient had a protracted
ostoperative course until respiratory failure on the 15th post-
perative day caused by the ﬁstula. We  had considered MIE  an
cceptable surgical alternative in order to minimize the risk for res-
iratory complications in this high risk patient. In order to reduce
ir leakage from the ﬁstula and improve conditions for healing, a
elf expandable stent was placed in the gastric remnant. In addition,
ow ventilator pressures (8–10 mm Hg) was considered beneﬁcial
Fig. 3. A chest X-ray demonstrating stent in placand the right intermediary bronchus (arrow), bilateral pleural effusion and lung
for healing of the ﬁstula. Some degree of hypercapnia was accepted
with these ventilator settings.
The ﬁstula was  probably caused by thermal injury of the right
bronchus by the close dissection with Ligasure 5 mm with blunt
tip. When using Ligasure the heat transmission is known to be
within 2 mm from the jaw of the instrument (Covidien). The ﬁs-
tula development probably started with ischemic necrosis of the
intermediate bronchus creating a ﬁstulous tract that advanced into
the anastomosis. Erosive injury by the staples can not be excluded.
This is, however, considered less likely since the staplers do not
transgress the lateral edge of the transected tissue of the intact
gastric remnant. Non-surgical intervention caused healing of the
ﬁstula in our case. Open surgery for the bronchial ﬁstula [7,8] in this
patient, with closure of the bronchial defect by suture, or with inter-
ponated tissue (pleura, oment or muscular ﬂap) was  considered as
having an unacceptable risk.
The optimal treatment for gastrobronchial and gastrotracheal
ﬁstulas after posterior route mediastinal esophagectomy and
intrathoracic esophagogastric anastomosis is still controversial,
because of variable results with a high incidence of serious mor-
bidity and considerable mortality [9,10]. The mainstay of treatment
is surgical in one or two  stages depending on severity of the leak-
e (arrow) and resolution of lung changes.
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ge, size of the ﬁstula, blood supply of the conduit and the general
ealth of the patient. One stage surgery comprises closure of the
efect in the airways and the conduit with buttressing with inter-
onate of oment, pleura or more often a pedicled muscle ﬂap.
urgery in two stages usually include (i) total or partial resection
f the conduit, and closure or more seldom resection of the airway
efect with lobectomy, (ii) exteriorization of proximal esophagus
esophagostomy) and nutrition by a jejunal cathether. In the second
tage the continuity of the gut is restored either with an anas-
omosis between esophagus and the initial but partially resected
onduit or by colon or jejunum. Of the 44 patients reported with
racheobronchial ﬁstula after surgery regardless of etiology [9,11],
4 patients developed gastrobronchial ﬁstula after esophagectomy
or cancer and the mean mortality rate was 25% (range 0–100%).
f conservative treatment can reduce this high mortality it should
e attempted. Esophagogastric stenting of a dehisced anastomo-
is per se has in recent years shown promising results [12] with
ncreased healing rates and survival compared with external and
asogastric drainage. However, stent migration has been reported
n as many as 37.5% of patients [13] when using the self expandable
lastic and covered Polyﬂex stent. Publications on stenting for GBF
fter esophagectomy for cancer within one month (early) and after
–4 months (late) after surgery without recurrent cancer is limited
10,14,15]. Fistulas to the right and left main stem bronchus in 6
atients were reported. In three of the four early postoperative ﬁs-
ulas healing occurred (75%) and the patients survived. In one of
hese survivors stenting of trachea was also necessary in order to
eal the the ﬁstula. The fourth patient had a covered tracheal stent
nserted for the presumed proximal gastrobronchial ﬁstula, but
ied from respiratory problems and sepsis. The two patients with
ate ﬁstulas were, in one case stented twice with 2 months inter-
al due to distal stent migration. In the other case the patient was
oo debilitated to undergo surgical repair of the ﬁstula and the ini-
ial treatment was insertion of an uncovered self-expanding metal
tent but he ﬁstula remained unhealed. Therefore an Amplatzer
eptal Occluder composed of nitinol metal and polyester fabric was
uccessfully introduced and closed the ﬁstula. The patient subse-
uently had no airway symptoms but was readmitted to hospital
fter 4 weeks with Streptococcus milleri sepsis complicated with
erebral abscesses and died after two weeks. Stents used in the 6
atients were Polyﬂex stents of length 12 cm and diameter 25 mm
Rusch AG, Wiesbaden, Germany) and covered or uncovered Ultra-
ex stents of length 12 cm and diameter 18 mm (Boston Scientiﬁc,
atic, MA). Accordingly, overall stent migration occurred in one
f six patients (16,7%) and the mortality rate was 2 of 6 patients
33,3%).
Stent migration and subsequent endoscopic manipulation and
estenting may  disturb the healing of the ﬁstula. Use of covered
tent is mandatory to seal the ﬁstula, and thereby minimize leak-
ge of air and digestive juice through the ﬁstula. However, use of a
tent which is exclusively uncovered in both ends, like the partially
overed Wall ﬂex stent used in the patient with DM,  would pre-
umable be more strongly anchored to the esophageal and gastric
ucosa and accordingly exhibit less potential for migration. There
s lower frequency of stent migration by using self expanding stents
f metal (Ultraﬂex and Wall stent) (7,6%) instead of plastic (Polyﬂex
tent) (57%) [16]. When considering stenting of a GBF communicat-
ng with the esophagogastric anastomosis adequate blood supply
f the gastric conduit is important. In additon, the smaller the ﬁs-
ula opening (tentatively <7–8 mm)  the greater is the possibility
f ﬁstula healing on the ariway side. Often stenting may  be the
nly treatment option in a patient too debilitated for surgery. In a
atient with a well-circulated conduit gastrobronchial ﬁstula stent-
ng should be considered as a ﬁrst treatment option, but surgery,
hen needed, must be carried out if this is not successful.PEN  ACCESS
rgery Case Reports 17 (2015) 31–35
In case of our patient with MD we are of the opinion that surgery
would have been a high risk procedure because of myopathy of
respiratory muscles.
4. Conclusions
Gastrobronchial ﬁstula is a rare and potentially lethal compli-
cation following esophagectomy for cancer, especially in a patient
with MD  type 1 and ventilatory insufﬁciency because of respiratory
muscle myopathy. The ﬁstula was  most likely caused by Liga-
sure induced thermal injury during dissection resulting in ischemic
necrosis of the intermediary bronchus. Limited gastrobronchial
ﬁstulas may  be successfully treated with stenting of the gastric
remnant in order to seal the ﬁstula. Low pressure ventilation prob-
ably improves healing. Our case demonstrates that MIE  can be an
acceptable surgical method for the treatment of esophageal cancer
in MD patients.
In patients with well-circulated gastric conduit and limited size
of the gastrobronchial ﬁstula from the esophagogastric anastomo-
sis to the main bronchi, insertion of a stent should be considered as
a relevant treatment option.
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